LY3031207

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3031207, covering 2019-06-27 to 2019-07-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3031207 in Healthy Subjects [Phase 1]